CompletedPhase 2NCT01168219
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Ravi VijAlliance for Clinical Trials in Oncology
- Intervention
- Allogeneic Hematopoietic Stem Cell Transplantation(procedure)
- Enrollment
- 68 enrolled
- Eligibility
- 18-74 years · All sexes
- Timeline
- 2010 – 2020
Study locations (17)
- Beebe Medical Center, Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States
- AdventHealth Orlando, Orlando, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States
- University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States
- Christiana Care - Union Hospital, Elkton, Maryland, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
- Cooper Hospital University Medical Center, Camden, New Jersey, United States
- Northwell Health NCORP, Lake Success, New York, United States
- Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States
- North Shore University Hospital, Manhasset, New York, United States
- Mount Sinai Hospital, New York, New York, United States
- NYP/Weill Cornell Medical Center, New York, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01168219 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.